Stevanato Group S.p.A (STVN) Cash & Equivalents (2020 - 2026)
Stevanato Group S.p.A's (STVN) quarterly Cash & Equivalents came in at $130.7 million in Q1 2026, up 37.01% year-on-year from $95.4 million in Q1 2025, and down 14.0% on a QoQ basis from $152.0 million in Q4 2025.
Stevanato Group S.p.A (STVN) Cash & Equivalents (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has 7 years of Cash & Equivalents data on file, last reported at $130.7 million in Q1 2026.
- On a quarterly basis, Cash & Equivalents rose 37.01% year-over-year to $130.7 million in Q1 2026; TTM through Mar 2026 was $130.7 million, a 37.01% increase from a year earlier, with the FY2025 full-year figure at $152.0 million, up 44.73% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $130.7 million, down from $152.0 million in the prior quarter.
- Over the last five years, Cash & Equivalents for STVN reached as high as $411.6 million in Q1 2022 and fell as low as $66.7 million in Q2 2023.
- Historically, Cash & Equivalents has averaged $160.0 million across 5 years, with a median of $130.7 million in 2026.
- Across the five-year window, Cash & Equivalents surged 176.85% in 2022 and sank 80.16% in 2023, its largest moves.
- Year by year, Cash & Equivalents stood at $233.4 million in 2022, then sank by 67.91% to $74.9 million in 2023, then jumped by 40.27% to $105.0 million in 2024, then jumped by 44.73% to $152.0 million in 2025, then slipped by 14.0% to $130.7 million in 2026.
- Per Business Quant data, the three most recent Cash & Equivalents figures were $130.7 million in Q1 2026, $152.0 million in Q4 2025, and $132.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 1.58 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 2.76 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 813.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 2.24 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 1.66 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 435.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 138.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 561.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 1.06 Bn |
| 10 | Stevanato Group S.p.A | 5.29 Bn | 5.15 Bn | 88.01 Mn | 130.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 130.74 Mn |
| Dec 31, 2025 | 152.03 Mn |
| Sep 30, 2025 | 132.49 Mn |
| Jun 30, 2025 | 106.60 Mn |
| Mar 31, 2025 | 95.42 Mn |
| Dec 31, 2024 | 105.04 Mn |
| Sep 30, 2024 | 85.66 Mn |
| Jun 30, 2024 | 84.15 Mn |
| Mar 31, 2024 | 202.42 Mn |
| Dec 31, 2023 | 74.89 Mn |
| Sep 30, 2023 | 70.56 Mn |
| Jun 30, 2023 | 66.67 Mn |
| Mar 31, 2023 | 170.41 Mn |
| Dec 31, 2022 | 233.37 Mn |
| Sep 30, 2022 | 262.08 Mn |
| Jun 30, 2022 | 336.03 Mn |
| Mar 31, 2022 | 411.55 Mn |
| Dec 31, 2021 | 470.22 Mn |
| Sep 30, 2021 | 504.70 Mn |
| Jun 30, 2021 | 121.37 Mn |